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Objective: The aim of this study was to compare the relationship between skin tumor
thickness and homogeneity and to evaluate the accuracy of 14-MHz ultrasound while
measuring the thickness of different skin tumors.
Material and methods: The ultrasonographic and histological analysis of 72 skin tumors was
performed. Preoperative vertical tumor thickness (T) and structure of 12 melanomas,
34 melanocytic nevi and 26 basal cell carcinomas was assessed by 14-MHz ultrasonography.
After the tumors were excised the vertical thickness measurement (Breslow index, pT) was
performed by pathologist. According to the histological thickness all skin tumors were divided
to thin (≤1 mm) and thick (>1 mm). The accuracy of the 14-MHz ultrasound measurements and
correlation between the ultrasonographic and histological tumor thickness were estimated.
Results: Homogeneous structure was assessed for all thin (≤1 mm) and the majority (81.3%)
of thick (>1 mm) melanocytic skin tumors. Nonhomogeneous structure was estimated in
thin and thick basal cell carcinomas, accordingly 42.9% and 31.9%. Measurements of T and pT
correlated moderately in thick (>1 mm) tumors (r = 0.694), while in thin (≤1 mm) tumors
correlation was low (r = 0.336). Moderate correlation between ultrasonographic and histo-
logical thickness was computed for melanocytic skin tumors as well as for basal cell
carcinomas (r = 0.564 and r = 0.690).
Conclusions: Medium frequency ultrasound is not a reliable tool for the precise measurement
of thin (≤1 mm) skin tumors. Ultrasonography using a 14-MHz frequency transducer enables
more precisely to measure the thickness of basal cell carcinoma than melanocytic skin tumors.
The 14-MHz ultrasound is support tool to suggest the morphologic type of skin tumor.
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m e d i c i n a 5 0 ( 2 0 1 4 ) 1 5 0 – 1 5 5 151Fig. 1 – 14-MHz ultrasound image of skin melanoma
(T = 1.5 mm).1. Introduction
Ultrasound is a noninvasive technique that provides comple-
mentary information to the clinical examination of various
skin lesions, especially skin tumors. Ultrasonographic assess-
ment of skin tumor margins, thickness, echo pattern and its
location may aid the diagnosis, plan the treatment or detect
subclinical recurrence of the tumor after treatment.
The prediction of surgical margins of skin melanoma and
performance of sentinel lymph node biopsy are based on the
tumor thickness assessed according to Breslow [1–3]. Exci-
sional biopsy with histological analysis is the best way to
determine the precise tumor thickness. However, it may
damage the lymphatic vessels, altering the pattern of tumor
drainage, particularly in anatomic regions with ambiguous
lymphatic circulation (e.g., neck and trunk) [4–6].
Basal cell carcinomas (BCCs) are more accurately identiﬁed
and measured ultrasonographically, often yielding the larger
measurements than those obtained at clinical examination
which can be particularly important at locations with a higher
risk of recurrences, mainly face [7–9]. According to the 7th
edition of the American Joint Committee on Cancer Classiﬁ-
cation (AJCC), the thickness more than 2 mm of BCC has been
included as one of the high-risk factors for tumor staging [10].
Ultrasound allows the surgical planning of BCC to be adapted
by identifying the extent of the tumor. It can also help to
monitor the early detection of recurrence of BCC [11–13].
In previous studies investigators have evaluated good
accuracy of the ultrasonography with higher than 20-MHz
scanners to determine the margins and thickness of BCC and
skin melanoma [4,5,8,14]. Assessment of skin melanoma
thickness using transducers of 100-MHz frequency has better
agreement with histology compared to 20-MHz ultrasonogra-
phy. There is the tendency of 20-MHz device to overestimate
tumor thickness because of several factors, e.g. tumor
regression, lymphocytic inﬁltration [15]. However, in case of
100-MHz ultrasonography, the ultrasonic penetration depth is
limited to 1.5 mm [5]. In the recent years technologic advances
have improved the quality of the more commonly available
ultrasonic scanners having frequency close to 15 MHz, allow-
ing axial and lateral resolutions of 0.1 mm in superﬁcial planes
at those frequencies [16]. There are reported data showing
higher agreement between ultrasonically and histologically
determined thickness in thicker (>2 mm) skin melanomas
and lower in thinner (1–2 mm) skin melanomas while using a
14-MHz ultrasound transducer [17]. Other investigators give a
high accuracy of 10-MHz ultrasound measurements when
evaluating skin melanomas of >1 mm thickness [18]. The
thickness of BCC can be accurately estimated when using a
7–15-MHz ultrasound transducer [7]. Higher frequency ultra-
sonography can show nonhomogeneously scattered internal
echoes in basal cell carcinoma and homogeneous reﬂex
pattern in melanoma [11,19]. There is insufﬁcient information
about the effectiveness of 14-MHz ultrasound when estimat-
ing the homogeneity of skin tumors.
According to these controversial results we designed a
study to evaluate the accuracy of 14-MHz ultrasound for the
preoperative assessment of the thickness and structure of
melanocytic skin tumors and BCC.2. Material and methods
A total of 72 patients (26 men and 46 women) with clinically
and dermatoscopically identiﬁed melanocytic tumors and
BCCs in various locations before the excision were included in
the study. The study was carried out from January 2010
through 2011. The tumor structure and thickness were
evaluated ultrasonographically before surgical treatment.
The maximum tumor thickness (T) measurements were made
in B-scan from the lower edge of the entry echo to the inferior
boundary of the echo-poor region representing the tumor
(Figs. 1 and 2). Vertical tumor thickness of 34 melanocytic
nevi, 12 melanoma and 26 basal cell carcinoma was
preoperatively assessed using a 14-MHz Toshiba Xario XG
ultrasonic scanner (Tokyo, Japan). All skin tumors were
surgically excised and processed for routine histopathology.
The vertical distance from the uppermost level of the stratum
granulosum in the epidermis to the lowest point of the tumor
(Breslow index, pT) was recorded in mm. The pathologist who
measured the tumor thickness did not know the thickness of
the lesion estimated by ultrasonography. According to the
histological thickness (pT) all skin tumors were divided to thin
(≤1 mm) and thick (>1 mm). Melanocytic skin tumors (mel-
anocytic nevi and melanoma) were analyzed together in one
group. Distribution of internal echoes (homogeneous or
nonhomogeneous) was assessed in skin tumors according
to the morphological analysis of an ultrasonographic struc-
ture by Altmeyer and Hoffman [19]. Analyses were conducted
using SPSS statistical software (version 13.0, SPSS for
Windows). The descriptive summary statistics and techni-
ques include frequencies, means, standard deviations,
standard errors and graphs. The nonparametric Wilcoxon
test, Spearman correlation coefﬁcient, and chi-square test (x2)
were used for statistical analysis. The data were given as
mean values and 95% conﬁdence interval (95% CI) as deemed
appropriate. Sensitivity, speciﬁcity, and accuracy of the
14-MHz ultrasonography method were calculated when using
standard descriptions and formulas for these values given
under Table 2.
Table 1 – Location of skin tumors assessed by 14-MHz
ultrasonography.
Location Melanocytic
nevi
Melanoma Basal cell
carcinoma
Head and face 3 2 10
Trunk 24 4 9
Upper extremities 2 2 2
Lower extremities 5 4 2
Other 0 0 3
Total 34 12 26
Values are numbers.
Fig. 2 – 14-MHz ultrasound image of basal cell carcinoma
(T = 2.5 mm).
m e d i c i n a 5 0 ( 2 0 1 4 ) 1 5 0 – 1 5 51523. Results
The mean age of 72 patients enrolled in this study was 49.29
years (range, 18–80 years). The locations of the investigated 72
skin tumors are presented in Table 1. Most cases of
melanocytic nevi were located on trunk, while skin melanoma
on the trunk or lower extremities, and BCC on the head, the
face, or the trunk, correspondingly.
Histologically there was estimated the thickness of ≤1 mm
in 37 lesions and >1 mm in 35 tumors. The 14-MHz ultrasound
measurements of skin tumors showed a sensitivity of 79.3%, a
speciﬁcity of 67.4%, NPV of 82.25%, PPV of 62.2%, and
accuracy of 72% (Table 2). When estimating by 14-MHz
frequency ultrasonic transducer 12/72 skin tumors hadTable 2 – Thickness of skin tumors measured using 14-MHz u
Ultrasound measurements Histological measur
Melanocytic tumors pT
≤1 mm
≤1 mm 19 (a) 
>1 mm 4 (c) 
All 23 
Basal cell carcinoma pT
≤1 mm
≤1 mm 4 (a) 
>1 mm 2 (c) 
All 6 
Skin tumors of both types pT
≤1 mm
≤1 mm 23 (a) 
>1 mm 6 (c) 
All 29 
pT, histological thickness; PPV, positive predictive value; NPP, negative p
For melanocytic tumors: sensitivity a/(a + c) = 19/(19 + 4) = 82.6%, speciﬁc
a/(a + b) = 19/(19 + 11) = 75%, accuracy (a + d)/(a + b + c + d) = 31/46 = 67%.
For basal cell carcinomas: sensitivity a/(a + c) = 4/(4 + 2) = 66.7%, speciﬁcity
(a + b) = 4/(4 + 3) = 57.14%, accuracy (a + d)/(a + b + c + d) = 21/26 = 80%.
For skin tumors of both types: sensitivity a/(a + c) = 23/(23 + 6) = 79.3%
= 82.85%, PPV a/(a + b) = 23/(23 + 14) = 62.2%; accuracy (a + d)/(a + b + c + d) nonhomogeneous structure and 60/72 homogeneous struc-
ture. Homogeneous structure was assessed for all thin (≤1 mm)
and the majority (81.3%) of thick (>1 mm) melanocytic skin
tumors. Nonhomogeneous structure was estimated in thin
(≤1 mm) and thick (>1 mm) basal cell carcinomas, accordingly
42.9% and 31.9%.
The mean thickness of thin (≤1 mm) tumors using a 14-MHz
frequency ultrasonic transducer was 0.71 mm (95% CI, 0.65–
0.78) compared to 1.14 mm (95% CI, 0.86–1.43) determined by
histometry. The ultrasonographic mean thickness of thick
(>1 mm) tumors was 2.07 mm (95% CI, 1.76–2.37) compared to
2.5 mm (95% CI, 1.95–3.05) determined histologically. The
comparison of T and pT measurements showed a low
correlation of 0.336 in thin (≤1 mm) skin tumors and a
moderate correlation of 0.694 in thick (>1 mm) lesions
(Table 3). The thickness measured by a 14-MHz ultrasonic
transducer had a good correlation for basal cell carcinoma
(r = 0.690), although a lower accuracy (r = 0.564) for melano-
cytic tumors (Table 4). Ultrasonographic measurements
correlated well with the histological data in thick (>1 mm)
melanocytic skin tumors and basal cell carcinoma (r = 0.783ltrasonography versus histological measurements.
ements All Prognostic value
pT
>1 mm
11 (b) 30 63.3% (PPV)
12 (d) 16 75% (NPV)
23 46
pT
>1 mm
3 (b) 7 57.14% (PPV)
17 (d) 19 89.47% (NPV)
20 26
pT
>1 mm
14 (b) 37 62.2% (PPV)
29 (d) 35 82.25% (NPV)
43 72
redictive value.
ity d/(d + b) = 12/(12 + 11) = 52%, NPV d/(c + d) = 12/(4 + 12) = 63.3%, PPV
 d/(d + b) = 17/(17 + 3) = 85%, NPV d/(c + d) = 17/(2 + 17) = 89.47%, PPV a/
, speciﬁcity d/(d + b) = 29/(29 + 14) = 67.4%, NPV d/(c + d) = 29/(6 + 29)
= 52/72 = 72%.
Table 3 – Correlation between the histological and ultrasonographic estimation of thin and thick skin tumors using a
14-MHz frequency transducer.
Thickness (pT) of skin
tumors
Number Mean ultrasonographic
tumor thickness (mm)
(95% CI)
Mean histometric
tumor thickness (mm)
(95% CI)
Spearman correlation
coefﬁcient
(r)
Thin (≤1 mm) 37 0.71 (0.65–0.78) 1.14 (0.86–1.43) 0.336
Thick (>1 mm) 35 2.07 (1.76–2.37) 2.50 (1.95–305) 0.694
pT, histological thickness in mm.
Table 4 – Correlation between the histological and ultrasonographic estimation of melanocytic tumors and basal cell
carcinomas using a 14-MHz frequency transducer.
Skin tumors Number Mean ultrasonographic
tumor thickness (mm)
(95% CI)
Mean histometric
tumor thickness (mm)
(95% CI)
Spearman
correlation coefﬁcient
(r)
Melanocytic tumor 46 1.19 (0.93–1.45) 1.81 (1.31–2.31) 0.564
Basal cell carcinoma 26 1.68 (1.31–2.06) 1.79 (1.43–2.15) 0.690
Table 5 – 14-MHz ultrasonography thickness agreement with histology in thin and thick melanocytic tumors and basal cell
carcinomas pT, histological thickness in mm.
Skin tumors
(pT)
Number Mean ultrasonographic
tumor thickness (mm)
(95% CI)
Mean histometric tumor
thickness (mm)
(95% CI)
Spearman correlation
coefﬁcient
(r)
Melanocytic skin tumor (≤1 mm) 30 0.70 (0.63–0.76) 1.14 (0.80–1.48) 0.417
Basal cell carcinoma (≤1 mm) 7 0.79 (0.56–1.01) 1.16 (0.56–1.75) 0.860
Melanocytic skin tumor (>1 mm) 16 2.13 (1.64–2.61) 3.06 (1.96–4.17) 0.783
Basal cell carcinoma (>1 mm) 19 2.02 (1.60–2.44) 2.03 (1.61–2.45) 0.720
Table 6 – Ultrasonographic and histological thickness of skin tumors according to their structure estimated using a 14-MHz
frequency transducer.
Skin tumors Number Mean ultrasonographic
tumor thickness (mm)
(95% CI)
Mean histometric
tumor thickness (mm)
(95% CI)
Spearman correlation
coefﬁcient
(r)
Homogenic structure 60 1.28 (1.05–1.52) 1.74 (1.37–2.10) 0.580
Nonhomogenic structure 12 1.82 (1.25–2.38) 2.14 (1.16–3.13) 0.717
m e d i c i n a 5 0 ( 2 0 1 4 ) 1 5 0 – 1 5 5 153and r = 0.720, respectively). While thin (≤1 mm) melanocytic
tumors showed a weak ultrasonographic and histological
correlation (r = 0.417), correspondingly in thin (≤1 mm) basal
cell carcinomas it was insigniﬁcant (P = 0.860) (Table 5). The
correlation between T and pT in skin tumors of nonhomoge-
neous structure was stronger (r = 0.717) than in those of
homogeneous structure (r = 0.580) (Table 6). A strong correla-
tion of T and pT was obtained in nonhomogeneous basal cell
carcinomas (r = 0.760), while the groups of homogeneous basal
cell carcinoma and homogeneous melanocytic skin tumors
had a moderate correlation (r = 0.603 and r = 0.567, according-
ly). There were only a few cases of nonhomogeneous
melanocytic skin tumors (Table 7).
4. Discussion
The ultrasound of 100-MHz frequency allows detailed visuali-
zation of the upper skin layers especially the horny layer and
small structures in it while 20-MHz ultrasound is valuable todiscriminate between the viable epidermis and papillary
dermis and tumor cell nets especially in BCC [20]. Due to
higher frequencies ultrasound provides higher resolution but
sacriﬁces tissue penetration so the ultrasonic transducers
from 7.5 up to 12–15 MHz are commonly used in clinical
practice to estimate the skin tumor thickness [5,14,17,21].
When the tumors extend beyond the dermis-subcutis border,
the demarcation may become difﬁcult because apart from
connective tissue septae, the subcutaneous fatty tissue is also
hypoechogenic. In most studies for evaluation of skin lesions
the investigators have used an ultrasonic transducer of 20 MHz
[22–33]. In the current study we have investigated the
possibility of using a 14-MHz ultrasonic transducer for
measuring skin tumor thickness before the surgical excision.
Our results have shown the ability of a 14-MHz ultrasonic
transducer to distinguish thick tumors better than thin though
in the studies of Vilana et al. and Music et al. the 10-MHz and
12–15-MHz ultrasonic transducers can reliably discriminate
between thin (≤1 mm) and thick (>1 mm) skin melanocytic
tumors [18,34]. Several factors could inﬂuence our results. A
Table 7 – Ultrasonographic and histological thickness of melanocytic tumors and basal cell carcinomas according to their
structure estimated using a 14-MHz frequency transducer.
Skin tumors Number Mean ultrasonographic
tumor thickness (mm)
(95% CI)
Mean histometric
tumor thickness (mm)
(95% CI)
Spearman correlation
coefﬁcient
(r)
Homogenic melanocytic tumor 43 1.14 (0.88–1.41) 1.72 (1.23–2.20) 0.567
Non-homogenic melanocytic tumor 3 1.93 (0.00–3.86) 3.13 (0.00–10.34) NA
Homogenic basal cell carcinoma 17 1.64 (1.15–2.12) 1.78 (1.30–2.27) 0.603
Non-homogenic basal cell carcinoma 9 1.78 (1.04–2.52) 1.81 (1.16–2.46) 0.760
NA, not applicable.
m e d i c i n a 5 0 ( 2 0 1 4 ) 1 5 0 – 1 5 5154larger sample size normally should lead to a better estimate of
accuracy as in the study it was found to be worthless when
measuring thin skin tumors. In our study the anatomic
localization of skin tumors was different and most of the
skin tumors were located on a head, face and trunk.
Ultrasonographic determined tumor thickness may exceed
the measurement of histological sections partly due to the
shrinkage of tissue processed for histology or probe pressure
during the ultrasound scanning. A similar situation occurs
while scanning a recurrent BCC because of the scar formation
caused by a previous cutaneous surgery [8,14,35]. In our study
when analyzing skin tumors according to the different
morphology higher correlation was estimated between the
histological and ultrasonographic thickness in basal cell
carcinomas than in melanocytic tumors. Bobadilla et al.
proved the strong correlation between the 7–15-MHz ultra-
sound depth measurements and histological measurements
when estimating 25 facial basal cell carcinomas [7]. In the
other studies the clinical dimensions (without histology) and
ultrasonographic measurements of basal cell carcinomas were
compared and the stress was put on lateral measurements of
basal cell carcinomas but not thickness [8,9].
Considering melanocytic skin tumors, there was an
estimated higher correlation between the histological and
14-MHz ultrasonographic examination in thick (>1 mm)
melanocytic tumors compared to thin (≤1 mm). Gamblicher
et al. observed the lower accuracy for ultrasonographic
measurements of melanocytic skin lesions with a tumor
thickness smaller than 1 mm using 20-MHz ultrasound while
Lassau et al. determined the strong correlation between the
thickness assessed by 20-MHz ultrasound and histology in 27
thin (≤1 mm) melanomas [5,36].
An inﬂammatory inﬁltrate or melanocytic nevus structures
underlying tumor is an important source of overestimation.
The inﬂammatory process weakens viable tissue causing the
decreased echogenicity than of normal skin, contributing to
the increased size of a skin tumor [27,35,36]. Similarly to the
other studies [18], the melanocytic skin tumors were mainly
visualized as homogeneous (hypoechogenic) structures within
the hyperechogenic dermis. BCCs were evaluated more
heterogenic tumors (showed a mixed echogenicity). When
comparing the BCCs of different homogeneity there was
identiﬁed better correlation between 14-MHz ultrasonographic
and histological thickness in nonhomogeneous BCCs.
Our study had several limitations. We did not assess the
reproducibility of the ultrasonographic (T) and histological (pT)
measurements (intraobserver variability). Skin tumors were of
different localization, and the low number of basal cellcarcinomas did not support the estimation of signiﬁcant
correlation between ultrasonographic and histological thick-
ness in that group. Despite that, the study attempted to
compare histological and 14-MHz ultrasonographic thickness
of skin tumors and made no assessment as to how this might
affect the treatment of skin tumors.
5. Conclusions
We conclude that 14-MHz ultrasound is not a reliable tool
for the precise measurement of thin (≤1 mm) skin tumors
thickness and it enables more precisely to measure the
thickness of BCCs than melanocytic skin tumors. 14-MHz
ultrasound is a support tool in diagnosing skin tumors as
structure of thin (≤1 mm) skin tumors could suggest the
morphologic type of tumor. The homogeneous structure is
speciﬁc for melanocytic skin tumors, while homogeneous and
nonhomogeneous structure is characteristic for BCCs.
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